Navigation Links
VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
Date:7/10/2008

-- Top-Line Data Expected in the Third Quarter --

SAN FRANCISCO, July 10 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it has completed the last patient visit in its carotid endarterectomy (CEA) study. The excised carotid plaque tissue will be analyzed to determine VIA-2291's effect on inflammation, and the company remains on track to report top-line data in the third quarter.

VIA-2291 is a potent small molecule drug that targets inflammation in the blood vessel wall, a primary disease process in atherosclerosis. It is being developed as a once-daily, oral drug to potentially decrease the risk of major adverse cardiac events associated with inflammation, including heart attack and stroke.

"Analyzing the carotid plaque collected in the CEA trial is a novel approach to aid investigators in the evaluation of VIA-2291's potential impact on inflammation," said Lawrence K. Cohen, Ph.D., chief executive officer of VIA Pharmaceuticals. "Our Phase 2 program, which includes this trial as well as two others, is designed to provide proof-of-concept evidence supporting the potential effectiveness of VIA-2291 and its further development."

The CEA study enrolled 50 patients and is designed to provide direct evaluation of VIA-2291's effect on inflammation by analyzing plaque removed from the carotid arteries of patients treated with VIA-2291 or placebo. CEA is a surgical procedure to remove plaque from the carotid artery to increase blood flow to the brain in patients with significant blockage in the artery to reduce the risk of stroke. Patients in the study are treate
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
2. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
3. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
4. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
5. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
6. Isis Pharmaceuticals Conference Call Notice
7. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
8. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
9. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
10. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
11. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  Lazarus Effect, a medical device company focused ... facilitate removal of blood clots, announced today that ... issued a new patent (U.S. Patent Number 8,795,305) ... TM and ReCover TM devices. ... stent-retriever (stentriever) with an integrated, novel, cover-based protection ...
(Date:7/24/2014)... , July 24, 2014 Consolidated Net ... Business Highlights   , India Business grew ... by 9.33% to Rs. 4,886.70 Mn Rest of World ... Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn ... , Glenmark Pharmaceuticals Limited, the research-led global ...
(Date:7/24/2014)... -- In any given hospital in the country at any ... one hospital-acquired infection, according to the Centers of Disease ... prove fatal. And as increased surveillance has shown that ... per year, infection control efforts have drifted to the ... stronger emphasis is being placed upon innovative and comprehensive ...
Breaking Medicine Technology:Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3
...  Medtronic, Inc, one of the world,s largest medical device ... U.S. Department of Justice (DOJ), the Office of the ... Services, and four relators in a qui tam suit ... in the U.S., including pacemakers and implantable cardioverter defibrillators ...
... A three-drug combination treatment for the blood cancer multiple myeloma ... patients, according to a multi-center study led by Andrzej ... the multiple myeloma program at the University of Chicago Medical ... of the phase I-II study on Dec. 12, 2011, ...
Cached Medicine Technology:Settlement Announced in Medtronic Qui Tam Case 2Drug Combination Highly Effective for Newly Diagnosed Myeloma Patients, Study Finds 2Drug Combination Highly Effective for Newly Diagnosed Myeloma Patients, Study Finds 3
(Date:7/24/2014)... The report, “Content Delivery Networks (CDN) Market”, defines ... with an in-depth analysis and forecasting of revenues. ... this market with insights on trends, opportunities, and ... 36 figures spread through 157 pages and in-depth ... http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html . , Early buyers will ...
(Date:7/24/2014)... In a July 9th article in the Money magazine ... Blossom Consulting LLC , was quoted in a Family Finance ... the High Cost of Infertility . Her advice began with, ... your chance of success from the first attempt.” The article ... “I am always happy to talk with the media about ...
(Date:7/24/2014)... Kathleen Doheny HealthDay Reporter ... children often don,t view their kids as unhealthy or recognize ... a new study. The children of the families surveyed ... the Hasbro Children,s Hospital in Providence, R.I. "A third ... study researcher Dr. Kyung Rhee, now an assistant professor of ...
(Date:7/24/2014)... care treatment of overweight and obese preschoolers works better ... when only the child is targeted, according to research ... at the University at Buffalo and Women and Children,s ... overweight or obese and had one parent who participated ... according to body mass index (BMI) measurements, calculated based ...
(Date:7/24/2014)... like a medical device or surgical implant is put ... to Northwestern University,s Guillermo Ameer, most of the time, ... function. , "You will always get an inflammatory response ... in Northwestern,s McCormick School of Engineering and Applied Science ... Medicine. "A problem with commonly used plastic materials, in ...
Breaking Medicine News(10 mins):Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 2Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 3Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:Overweight and obese preschoolers lose more weight when parent is also treated 2Health News:Overweight and obese preschoolers lose more weight when parent is also treated 3Health News:Antioxidant biomaterial promotes healing 2
... , WEDNESDAY, Sept. 21 (HealthDay News) -- How ... they see a pediatrician, dermatologist or internist, a new ... birth to age 18 are affected by psoriasis, a ... flaky, dry skin. Researchers from University of California, ...
... 21, 2011) A soy germ-based nutritional supplement containing ... skin wrinkles of the outer corner of the eyes ... S-equol have potential to slow skin aging, according to ... in the peer-review journal Menopause and presented ...
... America (ASA) will include more than 1,000 presentations in the ... speech; the science of music; the impact of noise on ... irritating impacts the way we learn, work, and play. ... place October 31 - November 4 in San Diego, California, ...
... (HealthDay News) -- Most of the 220,000 people who undergo ... follow-up procedures they could have to remove any loose skin ... surgeons. However, not all patients who undergo so-called ... dramatic weight loss, said one doctor who,s an obesity expert. ...
... whose work is advancing understanding of neurodegenerative diseases, has ... highest honors bestowed on an individual in the United ... of neurology in the UCSF Memory and Aging Center, ... dementia, a family of neurological syndromes usually afflicting ...
... can invade your bloodstream, break into your brain and ... contagious protozoa infect more than half the world,s population, ... Cornell researchers recently discovered how T. gondii ... it the first known parasite to control its host,s ...
Cached Medicine News:Health News:Kids With Psoriasis Get Inconsistent Care 2Health News:Soy-based natural S-equol supplements improve crow's feet skin wrinkles in menopausal women 2Health News:Soy-based natural S-equol supplements improve crow's feet skin wrinkles in menopausal women 3Health News:Acoustical Society meeting: Highlights and media registration 2Health News:Acoustical Society meeting: Highlights and media registration 3Health News:Acoustical Society meeting: Highlights and media registration 4Health News:Acoustical Society meeting: Highlights and media registration 5Health News:Acoustical Society meeting: Highlights and media registration 6Health News:Many Unaware of Plastic Surgery Options After Weight Loss Procedures 2Health News:UCSF neurologist William Seeley, M.D., named MacArthur Fellow 2Health News:UCSF neurologist William Seeley, M.D., named MacArthur Fellow 3Health News:UCSF neurologist William Seeley, M.D., named MacArthur Fellow 4Health News:Researchers discover how 'promiscuous parasites' hijack host immune cells 2Health News:Researchers discover how 'promiscuous parasites' hijack host immune cells 3
Reliable and Affordable. The Schuco 3000 Nebulizer by Allied has been designed to offer a compact style that provides worry-free affordable nebulizer therapy....
... CNBT technology, which relieves the practitioner of the ... HOPE allows you the ability to mix medications ... be easier, with a length of oxygen tubing ... the HOPE nebulizer into an inexpensive alternative to ...
... utilizing Vibrating Mesh Technology to efficiently ... from Asthma, COPD or other respiratory ... size and handy carrying case that ... them. Powerful delivery comparable to table-top ...
... dilution nebulizer allows the clinician to deliver up ... into the side port for precise high flow ... for normal flow patients, delivers 8-12 lpm in ... side port. For your high flow needs, DHD ...
Medicine Products: